NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Fetal Health


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Allos Therapeutics Announces New Data on FOLOTYN(TM) to be Presented at the American Society of Hematology Meeting
2009 NOV 23 ... treatment-related hematological toxicity and mucositis. FOLOTYN can cause fetal harm. Women should avoid becoming pregnant while being treated with FOLOTYN, and ... into consideration the importance of the drug to the mother. Keywords: , Health, Biotechnology, Clinical Trials, Oncology, Pharmaceutical, FDA, Electronics, Analogue, ...
Subject: Allos Therapeutics, Inc.
Price: $3.00
*
College of Veterinary Medicine publishes research in bone research
2009 NOV 23 ... gestation in C57BL/6J mice was associated with a marked reduction in late-gestation fetal skeletal developmental delay that included shorter long bone lengths, decreased average ... present work joins growing evidence that gestational environment (maternal nutrition, health, and chemical exposures) strongly influences prenatal development ...
Subject: Bone Research
Price: $3.00
*
Expectant moms, babies subjects of new Singapore study to prevent obesity and diabetes in adults
2009 NOV 29 ... total of 1,200 expectant mothers for the study, which initially will track children from fetal development to 3 years of age, and subsequently, if further funding is secured, as they ... lead investigator, Chong Yap Seng, M.D., of the National University Health System (NUHS), is working with a team of Singaporean and international researchers and ...
Subject: Agency for Science, Technology and Research A*STAR, Singapore
Price: $3.00
*
New findings from R. Cervera and co-researchers in the area of antiphospholipid syndrome described
2009 NOV 23 ... and 63 (81.8% of pregnant patients) had one or more live births. The most common fetal complications were early pregnancy loss (17.1% of pregnancies) and premature birth (35% ... Pregnancy, Pulmonary Embolism, Rheumatic Disease, Stroke, Therapy, Treatment, Women's Health. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Antiphospholipid Syndrome
Price: $3.00
*
New psychiatry research has been reported by scientists at Cardiff University
2009 NOV 28 ... "Adverse effects of maternal substance use during pregnancy on fetal development may increase risk of psychopathology. To examine whether maternal use of ... Country:Wales, Country:Wales, Life Sciences, Pediatrics, Pregnancy, Obstetrics, Women's Health, Psychopathology, Mental Health, Psychiatry, Cardiff University.This article ...
Subject: Psychiatry
Price: $3.00
*
Reports summarize veterinary research research from W.Z. Xue and co-authors
2009 NOV 23 ... concluded: "The results of this study demonstrate that the MLV vaccine reduces the fetal infection rate by at least 82% for BVDV type 1 and by 75% for BVDV type 2 when heifers ... additional information, contact W.Z. Xue, Intervet Schering Plough Animal Health, Biology Research & Development, 35500 W 91st St., De Soto, KS 66018, ...
Subject: Veterinary Research
Price: $3.00
*
Research conducted at University of Guelph has updated our knowledge about women's health
2009 NOV 23 ... rosiglitazone would (1) ameliorate the altered ovarian physiology that occurs following fetal and neonatal exposure to nicotine and (2) to examine whether this could be due to ... Ovarian Syndrome, Rosiglitazone, Thazolidinedione, Vasodilator Agent, Women's Health, University of Guelph. This article was prepared by Biotech Business Week ...
Subject: Women's Health
Price: $3.00
*
Research from Catholic University reveals new findings on vascular pharmacology
2009 NOV 24 ... on the presence of mechanisms sensing and signalling a diversity of stimuli during fetal development. The mechanisms that have been broadly suggested to be involved in these ... "The hypothesis of 'Developmental Origins of Health and Disease' (DOHaD) relies on the presence of mechanisms sensing and signalling a ...
Subject: Vascular Pharmacology
Price: $3.00
*
Research from University of Missouri yields new findings on biomedicine
2009 NOV 23 ... enhanced the development of SCNT embryos to the blastocyst stage when NIH inbred fetal fibroblast cells (FFCs) were used as donors compared with the untreated group (21% vs. ... "The National Institutes of Health (NIH) miniature pig was developed specifically for xenotransplantation and has been ...
Subject: Biomedicine
Price: $3.00
*
Research in the area of recurrence reported from McMaster University
2009 NOV 23 ... S.D. Mcdonald, McMaster University, Dept. of Obstetrics & Gynecology, Division Maternal Fetal Medical, 1200 Main St. W, HSC 3N52B, Hamilton, ON L8N 3Z5, Canada. ... of Disease codes were used to identify patients in the Canadian Institute for Health Information Discharge Abstract Database. The absolute and adjusted risks of recurrent ...
Subject: Recurrence
Price: $3.00
*
Researchers from Erasmus University detail findings in congenital heart disease
2009 NOV 23 ... = 0.017), small-for-gestational-age births (AOR = 1.95, 95% CI 1.15-3.30, P = 0.013) and fetal mortality (AOR = 5.55, 95% CI 1.77-17.4, P = 0.003). By contrast, no differences were ... Gynecology, Obstetrics, Preeclampsia, Pregnancy, Spontaneous Abortion, Women's Health, Erasmus University. This article was prepared by Biotech Business Week ...
Subject: Congenital Heart Disease
Price: $3.00
*
Studies from K.D. Gleaton et al provide new data on obstetrics and gynecology
2009 NOV 19 ... "Fetal lung maturity (FLM) studies using vaginal pool can guide management in near-term ... Keywords: United States, Charlotte, Life Sciences, Pregnancy, Gynecology, Women's Health, Obstetrics and Gynecology. This article was prepared by Women's Health ...
Subject: Obstetrics and Gynecology
Price: $3.00
*
Studies from Texas A&M University, Medical Department have provided new data on hypertension
2009 NOV 23 ... State:TX, Country:United States, Azathioprine Sodium, Blood Pressure, Drugs, Fetal Growth Retardation, Hypertension, Mycophenolate Mofetil, Pharmaceuticals, ... For additional information, contact B.M. Mitchell, Texas A&M University Systems, Health Science Center, College Medical, Dept. of Internal Medical, Temple, TX, USA. ...
Subject: Hypertension
Price: $3.00
*
Studies from York University yield new data on quality and safety in health care
2009 NOV 19 ... However, despite the emphasis on team training as a way to improve maternal and fetal safety outcomes, valid and reliable markers of obstetrical team performance are not ... Tregunno and colleagues published their study in Quality & Safety in Health Care (Development and usability of a behavioural marking system for performance ...
Subject: Quality and Safety In Health Care
Price: $3.00
*
The Global Market for Wound Care Management Products, Which Was Valued At Around $13 Billion in 2008, To Exceed $17 Billion By 2015
2009 NOV 23 ... Other emerging trends in wound care management include tissue engineering, animal-fetal cell research for regenerating tissue in chronic wounds, stem cell therapy and gene ... analysis of the emerging marketsReasons to buyKeywords: Health, Other Health, Nanotechnology, Asia, China, Economics, Economies, Electromagnet, ...
Subject: Research and Markets
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login